Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial.

Wanner C, Heerspink HJL, Zinman B, Inzucchi SE, Koitka-Weber A, Mattheus M, Hantel S, Woerle HJ, Broedl UC, von Eynatten M, Groop PH, EMPA-REG OUTCOME Investigators

Open source

DOI: 10.1681/asn.2018010103
Published: 2018 Nov
Container: Journal of the American Society of Nephrology : JASN
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1681/asn.2018010103,
  title = {Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial.},
  author = {Wanner C and Heerspink HJL and Zinman B and Inzucchi SE and Koitka-Weber A and Mattheus M and Hantel S and Woerle HJ and Broedl UC and von Eynatten M and Groop PH and EMPA-REG OUTCOME Investigators},
  year = {2018},
  journal = {Journal of the American Society of Nephrology : JASN},
  doi = {10.1681/asn.2018010103},
  url = {https://doi.org/10.1681/asn.2018010103}
}

RIS

TY  - JOUR
TI  - Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial.
AU  - Wanner C
AU  - Heerspink HJL
AU  - Zinman B
AU  - Inzucchi SE
AU  - Koitka-Weber A
AU  - Mattheus M
AU  - Hantel S
AU  - Woerle HJ
AU  - Broedl UC
AU  - von Eynatten M
AU  - Groop PH
AU  - EMPA-REG OUTCOME Investigators
PY  - 2018
JO  - Journal of the American Society of Nephrology : JASN
DO  - 10.1681/asn.2018010103
UR  - https://doi.org/10.1681/asn.2018010103
ER  -

APA

C, W., HJL, H., B, Z., SE, I., A, K., M, M., S, H., HJ, W., UC, B., M, V. E., PH, G., & Investigators, E. O. (2018). Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial.. Journal of the American Society of Nephrology : JASN. https://doi.org/10.1681/asn.2018010103

Source records

pubmed · retrieved 2026-09-25T15:07:33.322Z